A Study With CIT-013 in RA Patients

NCT06567470 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

88

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: CIT-013 low dose
DRUG: CIT-013 high dose
DRUG: Placebo
DRUG: CIT-013 medium dose

Sponsor

Citryll BV